Langerin⁺ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis

Area of Science:

• Immunology
• Dermatology
• Cell Biology

Background:

• Cutaneous fibrosis, including hypertrophic scars and keloids, occurs when tissue repair mechanisms fail post-injury.
• Langerin+ dendritic cells (DCs) are central players in regulating these repair processes.
• Dysregulation of immune, epithelial, and stromal cell communication underlies fibrotic conditions.

Purpose of the Study:

• To elucidate the central role of dendritic cells (DCs) in the pathogenesis of cutaneous fibrosis.
• To investigate the molecular mechanisms involving transforming growth factor-β1 (TGF-β1) activation and its downstream effects.
• To compare fibrotic processes with normal wound healing and identify therapeutic targets.

Main Methods:

• Review and synthesis of existing literature on cutaneous fibrosis.
• Analysis of cellular signaling pathways, including DC-keratinocyte-fibroblast interactions.
• Integration of insights from single-cell and spatial omics data.
• Exploration of therapeutic strategies targeting key molecular axes.

Main Results:

• DCs generate latent TGF-β1, which is activated by keratinocyte integrins (αvβ6/αvβ8), forming a "cytokine gate" that can promote fibrosis when dysregulated.
• Active TGF-β1, in conjunction with YAP/TAZ, drives fibroblast activation and matrix stiffening.
• Immune cell polarization (Th2, Th17, Treg, M2 macrophages) contributes to a pro-fibrotic environment.

Conclusions:

• Cutaneous fibrosis is orchestrated by a DC-centric network involving epithelial integrins and fibroblast mechanotransduction converging on TGF-β1.
• Understanding these interactions provides a framework for developing targeted therapies.
• Therapeutic strategies could focus on the αv integrin-TGF-β1 axis, YAP/TAZ, and immune modulation for combinatorial treatment approaches.